2025
Konecny GE*, Davidson TM*, Lebreton CL, Marsh LA, Chetram DK, Atkinson HJ, Larson MC, Oberg AL, Abdelaal N, Silverstein J, Jatoi A, Washburn A, Burton J, Dowdy S, Zhang L, Hallberg D, Velculescu VE, Slamon DJ, Wahner-Hendrickson AE. Phase II study of the efficacy and safety of palbociclib in patients with recurrent ovarian cancer. Int J Gynecol Cancer. 2025 Oct;35(10):102028. doi: 10.1016/j.ijgc.2025.102028. Epub 2025 Jul 28. PMID: 40839974. * co first authors
2024
Davidson TM, Hieken TJ, Glasgow AE, Habermann EB, Yan Y. Pregnancy-associated melanoma: characteristics and outcomes from 2002 to 2020. Melanoma Res. 2024 Apr 1;34(2):175-181. doi: 10.1097/CMR.0000000000000953. Epub 2024 Jan 23. PMID: 38265469
2023
Davidson TM, Lebreton CL, Hendricksen AEW, Atkinson HJ, Larson MC, Oberg AL, Provencher DM, Glaspy JA, Karlan BY, Slamon DJ, Konecny GE, Ray-Coquard IL. Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer. Gynecol Oncol. 2023 Mar;170:221-228. doi: 10.1016/j.ygyno.2023.01.021. Epub 2023 Jan 27. PubMed PMID: 36709663.
2023
Davidson, T. et al. Clinical Trial Diversity: Outcomes for US patients with advanced cancer in Phase 1 clinical trials at a major cancer center. 2023 AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorites and the Medically Underserved.
